Lance Goulet

860 total citations
14 papers, 639 citations indexed

About

Lance Goulet is a scholar working on Molecular Biology, Cell Biology and Epidemiology. According to data from OpenAlex, Lance Goulet has authored 14 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Cell Biology and 3 papers in Epidemiology. Recurrent topics in Lance Goulet's work include Sphingolipid Metabolism and Signaling (4 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Lance Goulet is often cited by papers focused on Sphingolipid Metabolism and Signaling (4 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Lance Goulet collaborates with scholars based in United States. Lance Goulet's co-authors include Hai‐Zhi Bu, Gretchen Bain, Deepak Dalvie, Dennis A. Smith, Ping Kang, R. Scott Obach, Chandra Prakash, Cho‐Ming Loi, Evan Smith and Susan Hurst and has published in prestigious journals such as The FASEB Journal, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Lance Goulet

13 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lance Goulet United States 11 379 109 83 81 68 14 639
Tanya Coleman United Kingdom 17 589 1.6× 115 1.1× 84 1.0× 282 3.5× 51 0.8× 28 1.1k
Emile G. Plise United States 17 493 1.3× 115 1.1× 84 1.0× 312 3.9× 14 0.2× 39 876
Vidula Sukhatme United States 8 353 0.9× 48 0.4× 73 0.9× 190 2.3× 22 0.3× 17 751
Joachim Blanz Germany 14 536 1.4× 51 0.5× 98 1.2× 202 2.5× 21 0.3× 31 967
Hank La United States 14 428 1.1× 44 0.4× 94 1.1× 221 2.7× 14 0.2× 23 792
Karsten Denner Germany 11 323 0.9× 169 1.6× 93 1.1× 108 1.3× 12 0.2× 19 660
Suhasini Joshi United States 16 434 1.1× 36 0.3× 28 0.3× 179 2.2× 78 1.1× 26 750
Mary J. Kuffel United States 14 272 0.7× 190 1.7× 59 0.7× 262 3.2× 26 0.4× 30 734
Yongchuan Gu New Zealand 21 662 1.7× 56 0.5× 104 1.3× 181 2.2× 109 1.6× 40 1.2k
Yoshiyuki Yabe Japan 11 270 0.7× 100 0.9× 27 0.3× 184 2.3× 30 0.4× 18 638

Countries citing papers authored by Lance Goulet

Since Specialization
Citations

This map shows the geographic impact of Lance Goulet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lance Goulet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lance Goulet more than expected).

Fields of papers citing papers by Lance Goulet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lance Goulet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lance Goulet. The network helps show where Lance Goulet may publish in the future.

Co-authorship network of co-authors of Lance Goulet

This figure shows the co-authorship network connecting the top 25 collaborators of Lance Goulet. A scholar is included among the top collaborators of Lance Goulet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lance Goulet. Lance Goulet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Kim, Sun Hee, Sangdon Han, Elizabeth Rico-Bautista, et al.. (2022). Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinism. Bioorganic & Medicinal Chemistry Letters. 71. 128807–128807. 2 indexed citations
3.
Rowbottom, Martin W., Gretchen Bain, Imelda Calderon, et al.. (2017). Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2). Journal of Medicinal Chemistry. 60(10). 4403–4423. 52 indexed citations
4.
Bain, Gretchen, Kristen E. Shannon, Fei Huang, et al.. (2016). Selective Inhibition of Autotaxin Is Efficacious in Mouse Models of Liver Fibrosis. Journal of Pharmacology and Experimental Therapeutics. 360(1). 1–13. 47 indexed citations
5.
Black, Katharine E., Evgeny Berdyshev, Gretchen Bain, et al.. (2016). Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis. The FASEB Journal. 30(6). 2435–2450. 35 indexed citations
6.
Castelino, Flavia V., Gretchen Bain, Katharine E. Black, et al.. (2016). An Autotaxin/Lysophosphatidic Acid/Interleukin‐6 Amplification Loop Drives Scleroderma Fibrosis. Arthritis & Rheumatology. 68(12). 2964–2974. 78 indexed citations
7.
Stein, Adam J., Gretchen Bain, Pat Prodanovich, et al.. (2015). Structural Basis for Inhibition of Human Autotaxin by Four Potent Compounds with Distinct Modes of Binding. Molecular Pharmacology. 88(6). 982–992. 51 indexed citations
8.
Johnson, Theodore R., Weiwei Tan, Lance Goulet, et al.. (2014). Metabolism, excretion and pharmacokinetics of [14C]crizotinib following oral administration to healthy subjects. Xenobiotica. 45(1). 45–59. 45 indexed citations
9.
Ernst, Justin T., Michael C. Liu, Samuel Sperry, et al.. (2014). Identification of Novel HSP90α/β Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration of Potential Utility in Treating CNS Disorders such as Huntington’s Disease. Journal of Medicinal Chemistry. 57(8). 3382–3400. 55 indexed citations
10.
Castelino, Flavia V., et al.. (2014). OP0241 Autotaxin is Over-Expressed in Systemic Sclerosis (SSC) Skin, Mediates Bleomycin-Induced Dermal Fibrosis via IL-6, and is A Target for SSC Therapy. Annals of the Rheumatic Diseases. 73. 153–153. 1 indexed citations
11.
Cheng, Hengmiao, Chunze Li, Simon Bailey, et al.. (2012). Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design. ACS Medicinal Chemistry Letters. 4(1). 91–97. 59 indexed citations
12.
Dalvie, Deepak, R. Scott Obach, Ping Kang, et al.. (2009). Assessment of Three Human in Vitro Systems in the Generation of Major Human Excretory and Circulating Metabolites. Chemical Research in Toxicology. 22(2). 357–368. 135 indexed citations
13.
Bu, Hai‐Zhi, Hovhannes J. Gukasyan, Lance Goulet, et al.. (2007). Ocular Disposition, Pharmacokinetics, Efficacy and Safety of Nanoparticle-Formulated Ophthalmic Drugs. Current Drug Metabolism. 8(2). 91–107. 60 indexed citations
14.
Brockman, Adam, et al.. (2000). Application of a non-indexed dual sprayer pneumatically assisted electrospray source to the high throughput quantitation of target compounds in biological fluids. Rapid Communications in Mass Spectrometry. 14(21). 2034–2038. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026